Baricitinib beneficial in head and neck AD

Presented By
Dr Eric Simpson, Oregon Health and Science University, USA
Trial
Phase 3, BREEZE-AD1 and BREEZE-AD2
Conference
AAD 2020
Type
Peer-reviewed article